Add time:07/12/2019         Source:sciencedirect.com

Replacing one of the morpholine groups of the phosphatidylinositol 3-kinase (PI3K) inhibitor ZSTK474 with a variety of sulfonamide-linked solubilizing substituents produced a new class of active and potent PI3Kα inhibitors, with several derivatives demonstrating high PI3Kα enzyme potency and good cellular potency in two human derived cell lines. The overall results suggest a preference for linear and somewhat flexible solubilizing functions. From this series, compound 16, also known as SN32976, was selected for advanced preclinical evaluation.

We also recommend Trading Suppliers and Manufacturers of 3-[3-(Benzyloxy)propyl]pyrrolidine (cas 1219967-44-8). Pls Click Website Link as below: cas 1219967-44-8 suppliers